Alternative lengthening of telomeres (ALT) is a telomerase-independent mechanism that some cancer cells use to maintain telomere length, enabling them to divide indefinitely. This process involves homologous recombination and other DNA repair pathways, making it a potential target for cancer therapies that aim to limit cellular immortality.